Mastocytosis - 30 Studies Found

Completed : Evaluation of Response of Dasatinib to Treat Mastocytosis
: Systemic Mastocytosis
: 2009-09-16
: Drug: Dasatinib Starting dosage 20mg once daily, that can be escalated up to 100mg once daily. Patient w
Completed : Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation
: Patients With Mastocytosis With Handicap and Bearing Mutations Asp-816-Val (D816V)
: 2010-12-23
: Drug: masitinib
Completed : Treatment of Indolent Systemic Mastocytosis With PA101
:
  • Mastocytosis
  • Systemic Mastocytosis
    : 2015-06-19
    :
    • Drug: PA101 40 mg PA101 admini
Terminated : Obatoclax for Systemic Mastocytosis
:
  • Leukemia
  • Systemic Mastocytosis

: 2009-06-09
: Drug: Obatoclax Mesylate 30 mg given by vein over 3 hours on Days 1-3 of each 14-day study cycle.
Completed : A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002
: Indolent Systemic Mastocytosis
: 2016-06-16
: Drug: AK002
Recruiting : Study of Mast Cell Precursors
:
  • Normal Physiology
  • Systemic Mastocytosis

: 1999-11-03
Completed : Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
:
  • Atopic Dermatitis
  • Healthy
  • Mastocytosis

: 1999-11-03
Completed : Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis
:
  • Non Neoplastic Condition
  • Precancerous Condition

: 2008-10-08
: Drug: thalidomide
Completed : A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
:
  • Gastrointestinal Stromal Tumors
  • Aggressive Systemic Mastocytosis : 2015-10-05
    : Drug: DCC-2618 10 mg and 50 mg formulated tablets
Completed : Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis
: Mastocytosis, Indolent Systemic
: 2025-08-03
<<< Previous